Professional
Added to YB: 2026-04-29
Pitch date: 2026-04-24
PRGO [bullish]
Perrigo Company plc
-2.46%
current return
Author Info
No bio for this author
Company Info
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
Market Cap
$1.6B
Pitch Price
$11.80
Price Target
N/A
Dividend
9.81%
EV/EBITDA
6.79
P/E
-1.17
EV/Sales
1.16
Sector
Pharmaceuticals
Category
turnaround
O'Keefe Stevens Advisory Added On Position: Perrigo Company plc
PRGO (added to position): Down 46% in 2025, hit $9.81 after Q4 miss, $1.3B goodwill impairment, 2026 EPS guide $2.00-$2.30 vs $2.75 in 2025. Infant formula rev -25% Q4, $360M segment under strategic review. Dermacosmetics sale Q2 2026 for debt paydown, $80-100M added cost cuts. Trades 4.8x fwd P/E, 8.6x EV/EBITDA, 0.4x sales. Core OTC can do $2.50+ EPS in few yrs. Activist or full sale likely vs dividend cut after 23yrs. Distressed valuation not secular decline.
Read full article (2 min)